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I used this title for my presentation recognizing that most members of the audience have an academic focus. I hope to encourage thought, by pointing out where universities really do play a role. The food and Drug administration (fDa) 
is a science-based agency and so the scientific expertise that universities can bring to bear 
on many of these issues is very important to decision making. Diversity of expertise is 
important.  
I am located at the Center for food Safety and applied nutrition and will focus on nu-
tritional aspects, describing the legal basis for the actions that we take—how my office uses 
its legal authority. I’ll finish with a description of our current activities and priorities.
fDa’s Legal authority
our legal authority is founded in three laws. The federal food, Drug, and Cosmetic 
act, as amended, is the primary law that governs what we do. everyone has great ideas 
about what fDa could do, but, in fact, our legal authority to regulate comes from the 
federal food, Drug, and Cosmetic act, the fair Packaging and Labeling act, and the 
Public Health Service act. The purpose of labeling is to inform the consumer at the point 
of purchase about the basic nature of the food, its ingredients, its nutritional attributes 
and other material or essential information, including warnings or clarifications. Iden-
tification of certain allergens is now mandatory in food labeling. The small print that 
is usually hard to read is often the mandatory part of food labeling. It has to be on the 
principal display panel or what’s defined as the information panel. other labeling—the 
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information that is typically most prominent—is usually voluntary and presented at the 
manufacturer’s discretion, i.e. claims, marketing statements, and promotions. It is im-
portant to remember that all labeling—whatever is on the product or stated on a related 
website about the product—must be truthful and not misleading. figure  lists the items 
that are considered mandatory elements for labeling in the United States. Canada’s laws 
are similar, and Canada and the United States are unusual in that nutrition information 
is mandatory in our labeling. europe is going through a process to develop mandatory 
nutrition labeling. 
figure . Mandatory label requirements for foods, including sdietary supplements.
Biotechnology
a noteworthy item that relates to biotechnology issues is the concept of material fact 
information; any information that reveals facts in light of representations already on the 
label or any consequences of the use of the product have to be included on the label. If 
biotechnology changes the product in a manner that is considered a material fact, you 
have to give consumers that material fact, i.e. not the biotech piece, but what is different 
about that product in terms of its composition or use.
nutrition Labeling
In 990, the nutrition Labeling and education act (nLea) was enacted, making nutrition 
information mandatory on most packaged foods, and the regulations specified a format. It 
was no longer left to the manufacturer’s discretion on how the information was presented. 
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It shifted emphasis toward the macronutrients that are associated with chronic disease 
risk and allowed for nutrient-content and health claims. The nLea provides consumers 
with information to help them select foods for healthier diets. It eliminated confusion 
about nutrient-content claims, ensuring that when a claim is made, consumers can rely 
on that information. It also protects consumers from unfounded claims by developing 
a process by which health claims are authorized. It also encourages product innovation 
through the marketing of nutritionally improved foods. for example, there was a major 
effort to get rid of trans-fat before its mandatory labeling went into effect. 
The public-health justification for enacting the nLea included a surgeon general’s 
Report on Nutrition and Health, a national academy of Sciences report, Diet and Health, 
and Dietary Guidelines for Americans jointly from the Department of Health and Human 
Services (DHHS) and the Department of agriculture (USDa), which made specific 
recommendations on how to improve health. Items to be listed on the “nutrition facts” 
label are shown in figure .
figure . Items to be quantified on the “nutrition facts” label.
There are cases where some nutrients need not be listed, but the details of those regula-
tions are beyond the scope of this presentation. 
The nutrition facts label was designed with education in mind. Several formats were 
consumer-tested, which led to the inclusion of the concept of “daily value,” to provide 
consumers with an easy means of judging whether a product is high or low in a nutrient, 
as part of planning their diets. The nLea contains education as part of its core, so it was 
important that the nutrition facts be useful in education.
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anPrM
an advanced notice of proposed rule-making (anPrM) lists the agency’s questions and 
requests information in order to engage in a rule-making process. Three of these have been 
published in recent years, seeking input on possible revision of the nutrition facts. one 
was on the display of calorie information on the food label. another was on serving size, 
particularly for products that can be reasonably consumed in one eating occasion; most 
of us are familiar with how we’ve gone from -ounce to 0-ounce sodas, exemplifying 
a need to reexamine serving size. and the third was major from a scientific perspec-
tive—revision of reference values and what the mandatory nutrients will be. This was 
driven particularly by the Dietary reference Intake reports from the national academy 
of Sciences, providing new scientific information for revising our reference values. The 
005 dietary guidelines will apply until the 00 process is completed.
Public-Health Context
In addition to considering scientific information, the public-health context is important. 
for example, prevalence of childhood and adolescent obesity has increased significantly 
since the late 90s. Sodium intake is another critical issue. Less than 5% of the US 
population consumes ,00 mg or less of sodium daily, most of which originates in pro-
cessed foods. another particularly relevant dimension involves those food groups whose 
consumption is encouraged. Looking at fruit consumption, we are not doing too badly 
in terms of the percentage of the population meeting the recommendations (fig. 3), 
whereas for vegetables we barely make it off the baseline, in terms of the percentage of 
the population meeting those recommendations. also for whole grains, very few people 
meet the recommendations (fig. 3).
figure 3. fractions of the US population consuming 
indicated servings of fruits, vegetable and grains, 003–00
(source national Health and nutrition examination Survey, CDC).
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Label Details
Serving size is at the top of the nutrition-facts label (fig. ). Do we have the right num-
bers? are we displaying calorie information appropriately? Many questions have been 
raised about calories from fat and whether this item is needed. Do we need to improve 
the presentation format? we’ve had comments about the footnote, which many don’t 
understand. Is there a better use for that space?
figure . The nutrition-facts label.
voluntary Information
from mandatory information on the nutrition facts label under the aegis of nLea, I 
want to shift to voluntary information. four general categories of claims can be used in 
nutrition labeling. Dietary-guidance and nutrition-support statements are not pre-ap-
proved by the agency. It’s the manufacturer’s responsibility to substantiate any such claims, 
and to make sure they are truthful and not misleading. a dietary-guidance statement is a 
general message that refers to categories of food, e.g. “fruits and vegetables are part of a 
healthy diet,” or “The food-guide pyramid recommends so many servings of vegetables,” 
or similar statements. we are in the process of examining dietary-guidance statements: 
should the agency be setting parameters dictating when dietary-guidance statements 
can be used on food products? nutrition-support statements include structure-function 
claims about maintaining health and function or structure of the body. for example, 
“Calcium builds strong bones” is a structure-function claim. again, in the United States, 
we do not pre-approve or review those. They are the manufacturer’s responsibility to be 
truthful and not misleading.
3 Promoting Health by Linking agriculture, food, and nutrition
Claims that need to be reviewed by the agency before they can be used are of 
two types:
• nutrient-content claims that refer to a nutrient level in a product, and 
• health claims that characterize the relationship between a food or food 
component and reduced risk of disease or a health-related condition.
Nutrient-Content Claims
figure 5 gives examples of “expressed nutrient-content claims” stating that a component 
is non-existent or low or a good source or an excellent source. They may be comparative 
claims, stating that a food has more of a nutrient than another or it has less of nutri-
ent, and particular types of percentage claims are used for dietary supplements. one of 
the challenges is making sure that we have the best tools and techniques for measuring 
nutrient content. The defined terminology, shown in figure 5, helps the consumer un-
derstand, for example, that, if something is described as an “excellent” source, it has a 
specific meaning.
figure 5. examples of expressed claims.
nutrient-content claims are not possible for many compounds, including some 
bioactives, because reference values are unavailable. we don’t know what constitutes a 
recommended amount, so it’s not feasible to state when a food is a good or excellent 
source. Most regulations that apply to nutrient-content claims are only for nutrient or 
dietary substances that have a daily value (fig. ). we don’t have that for antioxidants in 
general or for carotenoids, for example. again, that’s a challenge to science.
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There are also “implied” nutrient-content claims, which suggest that a nutrient is present 
or absent, or equivalent to the level in another product (fig. ). fDa has defined when the 
term “healthy” may be used, in terms of minimum fat, saturated fat, sodium, cholesterol 
and certain beneficial nutrients, providing context for the consumer (fig. ). 
figure . Basis for nutritional-content claims.
figure . Implied nutrient-content claims.
Health Claims
Health claims are science-based statements of disease-risk reduction from foods and dietary 
supplements without being regulated as drugs. Before nLea, the agency would have to 
approach such a declaration as a drug claim. Critically important is reduction in the risk of 
a certain type of disease; it’s not about prevention, mitigation, treating or curing a disease. 
a key element of a health claim is that the food or supplement has to contain a specific 
substance. also, the disease or health-related condition has to be defined.
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we’ve had some discussion about using biomarkers to estimate risk. Studies that 
require clinical outcomes—heart disease, cancer, etc.—are costly, therefore biomarkers 
offer a useful tool to show when risk has been reduced. we have five biomarkers that are 
validated surrogate endpoints of disease:
• LDL cholesterol or plasma cholesterol reduction for cardiovascular disease,
• blood-sugar levels or insulin resistance for diabetes,
• mild cognitive impairment for dementia.
• polyps for colon and rectal cancers, and
• bone-mineral density for osteoporosis.
an Institute of Medicine (IoM) project, funded by fDa, has the objective of devel-
oping a framework for elucidating more biomarkers to serve as surrogate endpoints of 
chronic disease. few such tools are applicable to cancer, for example, therefore it’s difficult 
to develop health claims in this area.
Three approaches are available for obtaining a health claim (fig. 9). nLea claims 
are based on significant scientific agreement. we authorize these through rulemaking, 
which means the agency stands behind the claim and makes it available through federal 
regulation. The agency developed qualified health claims as a result of a set of court cases 
that the agency lost, particularly with dietary supplements. These claims characterize the 
quality and strength of the scientific evidence because they are not based on significant 
scientific agreement; we do them only through enforcement discretion, not through 
figure . Criteria for the use of “healthy.”
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figure 9. Health claims in food labeling.
rulemaking. Thirdly, an authoritative statement from a branch of the government or the 
national academy of Sciences can be the basis of a health claim.
Significant scientific agreement implies consistent relevant evidence from well designed 
studies, whereas a qualified health claim is based more on emerging evidence, for which 
we use several types of qualifiers. Certain qualified claims are categorized as “highly 
unlikely” or “uncertain.” 
on our website, a final guidance document, titled “The evidence-Based review System 
for the Scientific evaluation of Health Claims,” details the steps the agency goes through 
to review the scientific evidence that is submitted with a petition. This would be a valuable 
aid for graduate students when designing their research, especially if they are working on 
something that eventually might relate to a health claim. figure 0 provides a schematic 
representation of the process. 
all relevant information must be submitted, not just favorable studies. we examine all 
of these, keeping in mind our guidance outlines for what kinds of information cannot 
be used for a scientific decision: review articles, meta analyses, book chapters, abstracts, 
animal and in vitro studies, non-identification of the substance or the disease, etc. (fig. 
0). we also identify fatal flaws within any of the studies, such as if there is no control, 
relevant statistics are lacking, or they have key confounders that are not controlled for. 
often we receive observational data without any intake validation, and studies that are 
conducted on malnourished populations; again we set those aside because they are not 
useful in the decision-making process. Having accumulated data that are useful to us, we 
go through an evaluation to determine whether or not they constitute credible evidence 
for the claim, because some will support the claim and some will not support it. If there 
is no credible evidence, then we deny the petition. If there is some credible evidence we 
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rank the level of scientific credibility, and then proceed with rulemaking for a significant 
scientific agreement (SSa) claim, or enforcement discretion for a qualified health claim 
(QHC). Many people think we use different evaluation processes for these two claims, 
which isn’t so. The strength of the scientific evidence determines the outcome.
regulation Development
as indicated, we implement the federal food, Drug and Cosmetic act, which is amended 
routinely. The two primary ways in which we implement the act are by adding to the 
Code of federal regulations (Cfr) and by publishing guidance documents. These go 
through a notice-and-comment process, which can take time.
a rulemaking process may be initiated several different ways. a judicial decision may 
be involved. I mentioned that, for updating nutrition facts, we started with an advanced 
notice of proposed rulemaking, asking questions. It then can become a proposed rule to 
which comment is invited, and eventually we get to a final rule. Many factors have to be 
considered, requiring a multi-disciplinary approach. The background material provides 
scientific justification. also, does the government have an interest from a public-health 
or other perspective in proceeding with the regulation? what are the petitions? what 
are the grounds for taking action? Does the fDa have the legal authority? How is the 
law interpreted to justify proceeding? There is also a first-amendment consideration. 
figure 0. The evidence-based review system.
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Labeling is deemed as speech, since we may be either compelling speech or suppressing 
speech, requiring a first amendment analysis. also, there has to be a regulatory-impact 
analysis, which is where economists contribute. we have to do a cost-benefit analysis on 
any rule under consideration, and the office of Management and Budget (oMB) would 
like to see that the benefit outweighs the cost; if that is not clear from the analysis, then 
it’s difficult to make progress in rulemaking. 
There is plenty of opportunity for scientific input. for example, on the nutrition side, 
we rely heavily on reports from the national academy of Sciences, and peer-reviewed 
scientific literature. we often engage with consultants either through advisory commit-
tees or public meetings, and experts may be consulted individually on a particular topic. 
The Federal Register describes everything, including notices, that we want comment on. a 
docket is opened, to which we solicit comments. Several dockets have been open recently; 
one on front-of-pack labeling and one on menu labeling, for example. These provide 
opportunities for the scientific community to give us comments. Most important are 
independent evaluations of scientific information that we need to consider. It’s nice to be 
offered opinion; however, opinion is never in short supply, so we look for the scientific 
evidence that is relevant. once we are finished within fDa, several other layers of review 
are required within the government before something is published. 
Current Priorities
a major area of interest right now is addressing labeling on the principal display panel, 
also referred to as front-of-pack labeling. Under this initiative, we have taken several en-
forcement actions. In early 00, we issued seventeen warning letters identifying claims 
on the front of food packages that are inconsistent with regulations and which we think 
are misleading to consumers. we have stated publicly that we are working on regulations 
regarding dietary-guidance statements to ensure that they are helpful to consumers in 
choosing diets consistent with the dietary guidelines. we are conducting consumer research 
on various front-of-pack labeling systems, to better understand how consumers use and 
comprehend those labels. and we have stated publicly that the agency intends to develop 
guidance on a government-sponsored approach to front-of-pack labeling, for which the 
research component will be critically important. and the Institute of Medicine of the 
national academy of Sciences has a study on front-of-pack labeling underway.
two other areas of high intensity are menu and vending-machine labeling. we are 
evaluating a national academy report on strategies to reduce sodium intake in the United 
States with a view to formulating a pathway forward for the agency. with respect to menu 
and vending-machine labeling, a directive tucked away in the many pages of the Patient 
Protection and affordable Care act is the requirement that chain restaurants and similar 
retail establishments with twenty or more locations disclose nutrient-content information 
for standard menu items, including specifically that calories should be listed on menus, 
menu boards and food on display. It also requires certain-sized vending-machine opera-
tors to disclose certain nutrient-content information, particularly calories, on items. The 
statute provides us with only  months to develop a regulation for these requirements 
of the statute.
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In Summary 
at fDa, science, policy and human behavior come together. Ultimately, our goal is to 
make sure that consumers have safe and nutritious food.
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